Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets
Cells · 31.12.2025 · 15 (1) · 72
DOI: 10.3390/cells15010072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 31.12.2025. Verfasst von Daniel Miron Brie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Disease Institute Timisoara, Gheorghe Adam Street, No. 13A, 300310 Timisoara, Romania. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Inflammation, Molecular Targeted Therapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babes” University of Medicine and Pharmacy Timisoara.
Abstract (Originalsprache)
Inflammation plays a pivotal role in the pathogenesis of acute coronary syndromes (ACS), contributing to plaque instability, thrombosis, and myocardial injury. This review aims to comprehensively examine the inflammatory mechanisms underlying ACS and evaluate current and emerging anti-inflammatory therapeutic strategies. We conducted a comprehensive literature review examining the role of inflammatory pathways in ACS pathophysiology, including innate and adaptive immune responses, key inflammatory mediators, and cellular mechanisms. We analyzed current evidence for anti-inflammatory therapies and their clinical outcomes in ACS management. Inflammatory processes in ACS involve complex interactions between innate immune cells (neutrophils, macrophages, monocytes) and adaptive immune cells (T lymphocytes, B cells). Key mechanisms include neutrophil extracellular trap (NET) formation, macrophage polarization, T cell subset imbalances (Th1/Th17 predominance with regulatory T cell dysfunction), and complement activation. Inflammatory biomarkers such as C-reactive protein, interleukin-6, and NET-specific markers demonstrate prognostic value. Anti-inflammatory therapies including colchicine, canakinumab (IL-1β inhibition), and methotrexate have shown cardiovascular benefits in clinical trials. Emerging targets include NET inhibition, T cell modulation, and precision inflammatory profiling approaches. Inflammation represents a critical therapeutic target in ACS beyond traditional risk factor modification. While colchicine and IL-1β inhibition have demonstrated clinical efficacy, future strategies should focus on precision medicine approaches targeting specific inflammatory pathways based on individual patient profiles. Integration of anti-inflammatory therapy with lipid management and antithrombotic strategies offers promise for improving ACS outcomes through comprehensive targeting of the multifactorial pathophysiology underlying coronary artery disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Disease Institute Timisoara, Gheorghe Adam Street, No. 13A, 300310 Timisoara, Romania.
- Research Center of the Institute of Cardiovascular Diseases, Gheorghe Adam Street, No. 13A, 300310 Timisoara, Romania.
- Department of Cardiology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
- Department of Pediatric Surgery and Orthopedics, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
- Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Tudor Vladimirescu Street, No. 14, 300174 Timisoara, Romania.
- ANAPATMOL Research Center, "Victor Babes" University of Medicine and Pharmacy, Tudor Vladimirescu Street, No. 14, 300174 Timisoara, Romania.
ORCID-Profile: Daniel Miron Brie, Cristian Mornoș, Roxana Popescu
Förderung
- “Victor Babes” University of Medicine and Pharmacy Timisoara
Zitieren
APA
Brie, D. M., Mornoș, C., Adam, O., Tîrziu, A., Popescu, R., & Brie, A. D. (2025). Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets. Cells, 15(1), 72. https://doi.org/10.3390/cells15010072
Vancouver
Brie DM, Mornoș C, Adam O, Tîrziu A, Popescu R, Brie AD. Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets. Cells. 2025;15(1):72. doi:10.3390/cells15010072
BibTeX
@article{Brie2025,
author = {Brie, Daniel Miron and Mornoș, Cristian and Adam, Ovidiu and Tîrziu, Alexandru and Popescu, Roxana and Brie, Alina Diduța},
title = {Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets},
journal = {Cells},
year = {2025},
volume = {15},
number = {1},
pages = {72},
doi = {10.3390/cells15010072}
}
EUVIMED